Penumbra (PEN) Other Non Operating Income (2014 - 2023)
Penumbra (PEN) reported Other Non Operating Income of -$444000.0 for Q3 2023, up 81.15% year-over-year from -$245094.7 in Q3 2022, and down 154.95% quarter-over-quarter from $808000.0 in Q2 2023.
Penumbra (PEN) Other Non Operating Income (2014 - 2023) Analysis & Trends
Penumbra (PEN) has 10 years of Other Non Operating Income data on file, last reported at -$444000.0 in Q3 2023.
- Other Non Operating Income for Q3 2023 came in at -$444000.0, up 81.15% year-over-year; the trailing twelve-month figure through Sep 2023 was $2.4 million (up 146.75% YoY), and the FY2022 annual result was -$2.3 million, up 40.92% from the prior year.
- Other Non Operating Income slipped to -$444000.0 in Q3 2023 per PEN's latest filing, from $808000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $2.0 million in Q4 2022 and troughed at -$2.4 million in Q3 2022.
- A 5-year average of -$335894.7 and a median of -$408000.0 in 2021 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2019 and 2021: Other Non Operating Income jumped 1445.45% in 2019, then slumped 8221.43% in 2021.
- A 5-year view of Other Non Operating Income shows it stood at $592000.0 in 2019, then jumped by 32.94% to $787000.0 in 2020, then sank by 216.65% to -$918000.0 in 2021, then surged by 317.43% to $2.0 million in 2022, then tumbled by 122.24% to -$444000.0 in 2023.
- Business Quant data shows PEN's Other Non Operating Income at -$444000.0 in Q3 2023, $808000.0 in Q2 2023, and $90000.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Penumbra | 12.45 Bn | 11.84 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -444,000.00 |
| Jun 30, 2023 | 808,000.00 |
| Mar 31, 2023 | 90,000.00 |
| Dec 31, 2022 | 2.00 Mn |
| Sep 30, 2022 | -2.36 Mn |
| Jun 30, 2022 | -956,000.00 |
| Mar 31, 2022 | -1.01 Mn |
| Dec 31, 2021 | -918,000.00 |
| Sep 30, 2021 | -1.14 Mn |
| Jun 30, 2021 | -408,000.00 |
| Mar 31, 2021 | -1.48 Mn |
| Dec 31, 2020 | 787,000.00 |
| Sep 30, 2020 | 14,000.00 |
| Jun 30, 2020 | 511,000.00 |
| Mar 31, 2020 | -1.66 Mn |
| Dec 31, 2019 | 592,000.00 |
| Sep 30, 2019 | -772,000.00 |
| Jun 30, 2019 | -71,000.00 |
| Mar 31, 2019 | 24,000.00 |
| Dec 31, 2018 | -44,000.00 |